---
schema_version: "secwatch.filing_event.v1"
accession: "0000009326-26-000016"
form_type: "8-K"
ticker: "BCPC"
cik: "0000009326"
company_name: "BALCHEM CORP"
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T01:29:06.980747+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Balchem Q1 net sales $270.7M (+8.1%); adjusted EBITDA $74.3M (+12.1%)

## Summary
- Net sales $270.7M, up 8.1% YoY; GAAP EPS $1.25, adjusted EPS $1.33.
- Adjusted EBITDA $74.3M (+12.1%); free cash flow $33.8M; operating cash flow $40.1M.
- All three segments posted sales and earnings growth; record Q1 net sales, EBITDA, and net earnings.
- New clinical fMRI study on VitaCholine suggests cognitive health benefits in post-menopausal women.
- CEO cites strong business model resilience; no guidance change despite geopolitical and trade uncertainty.

## SEC filing metadata
- accession: 0000009326-26-000016
- form_type: 8-K
- ticker: BCPC
- cik: 0000009326
- company_name: BALCHEM CORP
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/9326/000000932626000016/0000009326-26-000016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/9326/000000932626000016/bcpc-20260430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000009326-26-000016
- JSON: https://secwatch.observer/filing/0000009326-26-000016.json
- Plain text: https://secwatch.observer/filing/0000009326-26-000016.txt

## Key facts
- Earnings Releases
  BALCHEM CORP reported first quarter ended March 31, 2026 results: revenue $270.7 million, net income $40.3 million, EPS $1.25 per diluted share.
  - Period: first quarter ended March 31, 2026
  - Revenue: $270.7 million
  - Net income: $40.3 million
  - EPS: $1.25 per diluted share
  - Result: reported results
  source text: First Quarter 2026 Financial Highlights: • Net sales were $270.7 million, an increase of 8.1% compared to the prior year quarter. • GAAP net earnings were $40.3 million, an increase of 8.7% from the prior year quarter. • Adjusted EBITDA was $74.3 million, an increase of 12.1% from the prior year quarter. • GAAP earnings per share was $1.25 compared to $1.13 in the prior year quarter and adjusted earnings per share (a) was $1.33 compared to $1.22 in the prior year quarter.
  evidence_url: https://www.sec.gov/Archives/edgar/data/9326/000000932626000016/0000009326-26-000016-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.